Posted on 07/01/03
Ontario to fight for gene test
The Ontario government has set itself up for a showdown with the U.S. company that holds patents on the genes involved in breast and ovarian cancer.Myriad Genetics of Salt Lake City, Utah, has claimed intellectual property rights over the BRCA1 and BRCA2 genes, which contain information that can reveal a woman's risk of developing hereditary forms of breast and ovarian cancer.
The full text of this article has 691 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
